Description
Gentavin Injection is a high-potency antimicrobial solution containing Gentamicin Sulfate BP 80 mg, formulated by ANVIS for both intramuscular (IM) and intravenous (IV) administration. Designed to treat a broad spectrum of serious bacterial infections, Gentavin is particularly effective against Gram-negative organisms, including Pseudomonas aeruginosa, Proteus species, Escherichia coli, and Klebsiella. It also demonstrates efficacy against select Gram-positive pathogens when combined with other antibiotics.
Gentamicin works by disrupting bacterial protein synthesis, resulting in cell death. This mechanism of action makes it suitable for use in systemic infections such as septicemia, respiratory tract infections, urinary tract infections, and infections of the bone, skin, and abdomen. The product is packaged in a box containing 5 vials, each containing 2 ml of solution, allowing for flexible dosing and multi-day treatment courses based on physician guidance.
Manufactured under stringent quality assurance protocols, Gentavin is favored in hospital and clinical settings for its reliable performance, rapid onset of action, and compatibility with other antibacterial therapies. The sterile liquid formulation ensures safe handling and administration, with clear labeling to minimize dosing errors.
